3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
3
Stomatitis
2
Recurrence
2
Nasopharyngeal Carcinoma
2
Meningeal Carcinomatosis
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms
2
Anemia
2
Vitamin B 12 Deficiency
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Thrombocytopenia
1
Stroke
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neutropenia
1
Neuralgia
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Myocardial Infarction
1
Mesothelioma
1
Head and Neck Neoplasms
1
HR-positive Breast Cancer
1
Gliosarcoma
1
Interventions
Gemcitabine
8
pembrolizumab
5
Cisplatin
5
enfortumab vedotin
3
avelumab
3
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Carboplatin
3
vinflunine
2
Radiotherapy
2
Nephroureterectomy
2
Immunoglobulin G
2
Doxorubicin
2
Disulfides
2
vandetanib
1
tremelimumab
1
tocilizumab
1
tamibarotene
1
relatlimab
1
pegfilgrastim
1
merphos
1
guadecitabine
1
genexol-PM
1
enzalutamide
1
durvalumab
1
dehydroftorafur
1
atezolizumab
1
abexinostat
1
Vitamin D
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ureteral Neoplasms
×
Vitamin B 12
×
Clear all
NCT03193788
2017-06-21
PREMIER
Asan Medical Center
Phase 3
Unknown
74 enrolled